- Presentations
- 3
- Markets
- 1
Envarsus XR is a brand of Tacrolimus marketed by Veloxis Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tacrolimus
- Brand owner
- Veloxis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 0.75 mg extended-release tablet, 1 mg extended-release tablet, 4 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Envarsus XR 0.75 mg extended-release tabletOral | Veloxis Pharmaceuticals | US FDA | Available on request |
| Envarsus XR 1 mg extended-release tabletOral | Veloxis Pharmaceuticals | US FDA | Available on request |
| Envarsus XR 4 mg extended-release tabletOral | Veloxis Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Tacrolimus.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Envarsus XR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.